Last update 25 Oct 2025

Arachidonate 5-lipoxygenase inhibitors compound 15( King Faisal University)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
5-LOX
Action
inhibitors
Mechanism
5-LOX inhibitors(Arachidonate 5-lipoxygenase inhibitors)
Therapeutic Areas
Other Diseases
Active Indication
disorder of agingInflammationstress oxidative
Inactive Indication-
Originator Organization
Alexandria UniversityAlexandria UniversityKing Faisal UniversityKing Faisal University
Active Organization
Alexandria UniversityAlexandria UniversityKing Faisal UniversityKing Faisal University
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Arachidonate 5-lipoxygenase inhibitors compound 15( King Faisal University)
Login to view more data
100 Translational Medicine associated with Arachidonate 5-lipoxygenase inhibitors compound 15( King Faisal University)
Login to view more data
100 Patents (Medical) associated with Arachidonate 5-lipoxygenase inhibitors compound 15( King Faisal University)
Login to view more data
1
Literatures (Medical) associated with Arachidonate 5-lipoxygenase inhibitors compound 15( King Faisal University)
RSC Medicinal Chemistry
Combating oxi-inflamm-aging: Passerini adducts tethered with 1,2,3-triazoles for enhanced antioxidant defense and 5-LOX inhibition
100 Deals associated with Arachidonate 5-lipoxygenase inhibitors compound 15( King Faisal University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
disorder of agingPreclinical
Egypt
Alexandria UniversityAlexandria University
01 Jan 2025
disorder of agingPreclinical
Saudi Arabia
King Faisal UniversityKing Faisal University
01 Jan 2025
InflammationPreclinical
Egypt
Alexandria UniversityAlexandria University
01 Jan 2025
InflammationPreclinical
Saudi Arabia
King Faisal UniversityKing Faisal University
01 Jan 2025
stress oxidativePreclinical
Egypt
Alexandria UniversityAlexandria University
01 Jan 2025
stress oxidativePreclinical
Saudi Arabia
King Faisal UniversityKing Faisal University
01 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free